These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26937900)

  • 1. Comparison of the Degree of Exercise Tolerance in Children After Surgical Treatment of Complex Cardiac Defects, Assessed Using Ergospirometry and the Level of Brain Natriuretic Peptide.
    Mazurek B; Szydlowski L; Mazurek M; Markiewicz-Loskot G; Pajak J; Morka A
    Medicine (Baltimore); 2016 Feb; 95(8):e2619. PubMed ID: 26937900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of systemic ventricular function quantified by myocardial performance index (Tei) to cardiopulmonary exercise capacity in adults after Mustard procedure for transposition of the great arteries.
    Norozi K; Buchhorn R; Alpers V; Arnhold JO; Schoof S; Zoege M; Geyer S; Wessel A
    Am J Cardiol; 2005 Dec; 96(12):1721-5. PubMed ID: 16360364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
    Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
    Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure.
    Parovic M; Okwose NC; Bailey K; Velicki L; Fras Z; Seferovic PM; MacGowan GA; Jakovljevic DG
    ESC Heart Fail; 2019 Apr; 6(2):449-454. PubMed ID: 30788904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts.
    Elkiran O; Sandikkaya A; Kocak G; Karakurt C; Taskapan C; Yologlu S
    Pediatr Cardiol; 2013 Oct; 34(7):1583-9. PubMed ID: 23483243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.
    Felker GM; Whellan D; Kraus WE; Clare R; Zannad F; Donahue M; Adams K; McKelvie R; Piña IL; O'Connor CM;
    Am Heart J; 2009 Oct; 158(4 Suppl):S37-44. PubMed ID: 19782787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
    Lowenthal A; Camacho BV; Lowenthal S; Natal-Hernandez L; Liszewski W; Hills NK; Fineman JR; Bernstein HS
    Am J Cardiol; 2012 Mar; 109(6):866-72. PubMed ID: 22196786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between N-terminal pro-B-type natriuretic peptide and cardiac function in adults with corrected tetralogy of Fallot.
    Eindhoven JA; Menting ME; van den Bosch AE; Cuypers JA; Ruys TP; Witsenburg M; McGhie JS; Boersma E; Roos-Hesselink JW
    Int J Cardiol; 2014 Jul; 174(3):550-6. PubMed ID: 24798786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of NT-proBNP in assessment of right ventricular function in children after tetralogy of Fallot correction - a preliminary study.
    Pietrzak R; Werner B
    Kardiol Pol; 2009 Apr; 67(4):378-83. PubMed ID: 19492250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair.
    Norozi K; Buchhorn R; Kaiser C; Hess G; Grunewald RW; Binder L; Wessel A
    Chest; 2005 Oct; 128(4):2563-70. PubMed ID: 16236924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of N-terminal pro-B natriuretic peptide in the management of adult patients with congenital heart disease - Results from the CSONGRAD Registry].
    Ambrus N; Havasi K; Berek K; Kalapos A; Hartyánszky I; Bogáts G; Forster T; Nemes A
    Orv Hetil; 2018 Jan; 159(4):141-148. PubMed ID: 29353497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in N-terminal pro B-type natriuretic peptide levels and clinical outcomes in children undergoing congenital heart surgery.
    Gupta RK; Zheng H; Cui Y; Qu J; Li L; Liang H; Li K; Chen X; Xia H
    Int J Cardiol; 2019 May; 283():96-100. PubMed ID: 30833104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise training in advanced heart failure patients: discordance between improved exercise tolerance and unchanged NT-proBNP levels.
    Arad M; Adler Y; Koren-Morag N; Natanzon S; Sela BA; Ben Dov I; Shechter M; Schwammenthal E; Freimark D
    Int J Cardiol; 2008 May; 126(1):114-9. PubMed ID: 17651845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function.
    Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW
    Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declining cardiopulmonary exercise capacity is not associated with worsening systolic systemic ventricular dysfunction in adults with transposition of great arteries after atrial switch operation.
    Roentgen P; Kaan M; Tutarel O; Meyer GP; Westhoff-Bleck M
    Congenit Heart Dis; 2014; 9(3):259-65. PubMed ID: 24034170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Range and distribution of NT-proBNP values in stable corrected congenital heart disease of various types.
    Popelová J; Kotaška K; Černý S; Prokopová M; Rubáček M
    Can J Cardiol; 2012; 28(4):471-6. PubMed ID: 22482396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.